New eye injection targets Blindness-Causing lesions
NCT ID NCT06961370
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 36 times
Summary
This early-stage study tests the safety of an experimental drug called RO7669330, given as an injection into the eye, for people with geographic atrophy (GA) due to age-related macular degeneration (AMD). The study involves 27 participants and will monitor side effects and eye health. The goal is to see if the drug is safe enough for further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Associated Retina Consultants - Phoenix - DocTrials - PPDS
Phoenix, Arizona, 85020-5505, United States
-
Austin Clinical Research, LLC
Austin, Texas, 78750, United States
-
Barnet Dulaney Perkins Eye Center
Sun City, Arizona, 85351, United States
-
Charles Retina Institute
Germantown, Tennessee, 38138, United States
-
Cumberland Valley Retina Consultants PC
Hagerstown, Maryland, 21740, United States
-
Erie Retina Research
Erie, Pennsylvania, 16505, United States
-
Global Research Management
Glendale, California, 91204, United States
-
Retina Consultants of Texas - (The Woodlands)
The Woodlands, Texas, 77384, United States
-
Retina Consultants of Texas Westover Hills Retina Center
San Antonio, Texas, 78251, United States
-
Retina Northwest
Portland, Oregon, 97221, United States
-
Retina-Vitreous Associates Medical Group
Beverly Hills, California, 90211, United States
-
Retinal Consultants Medical Group Inc - Parkcenter Drive
Sacramento, California, 95825, United States
-
Southeast Retina Center
Augusta, Georgia, 30909, United States
-
Tennessee Retina PC
Nashville, Tennessee, 37203, United States
-
Texas Retina Associates
Dallas, Texas, 75231, United States
-
The Retina Institute
St Louis, Missouri, 63128, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.